Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease

Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8209-13. doi: 10.1073/pnas.90.17.8209.

Abstract

Since memory loss is characteristic of Alzheimer disease (AD), and since K+ channels change during acquisition of memory in both molluscs and mammals, we investigated K+ channel function as a possible site of AD pathology and, therefore, as a possible diagnostic index as well. A 113-pS tetraethylammonium (TEA)-sensitive K+ channel was consistently absent from AD fibroblasts, while it was often present in young and aged control fibroblasts. A second (166-pS) K+ channel was present in all three groups. Elevated external potassium raised intracellular Ca2+ in all cases. TEA depolarized and caused intracellular Ca2+ elevation in young and aged control fibroblasts but not AD fibroblasts. The invariable absence of a 113-pS TEA-sensitive K+ channel and TEA-induced Ca2+ signal indicate K+ channel dysfunction in AD fibroblasts. These results suggest the possibility of a laboratory method that would diagnostically distinguish AD patients, with or without a family history of AD, from normal age-matched controls and also from patients with non-AD neurological and psychiatric disorders.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / diagnosis*
  • Alzheimer Disease / genetics
  • Alzheimer Disease / physiopathology*
  • Calcium / metabolism
  • Cell Line
  • Cells, Cultured
  • Female
  • Fibroblasts / drug effects
  • Fibroblasts / physiology
  • Humans
  • Male
  • Middle Aged
  • Potassium / pharmacology
  • Potassium Channels / drug effects
  • Potassium Channels / physiology*
  • Psychotic Disorders / physiopathology
  • Reference Values
  • Skin / physiopathology*
  • Skin Physiological Phenomena
  • Tetraethylammonium
  • Tetraethylammonium Compounds / pharmacology

Substances

  • Potassium Channels
  • Tetraethylammonium Compounds
  • Tetraethylammonium
  • Potassium
  • Calcium